描述
Powered by Eupheria Biotech
產品線
MISSION®
形狀
lyophilized powder
esiRNA cDNA 標靶序列
GGACAGGAAGGACTTGGACAAGTTTATTAAGTTTTTTGCCCTCAAGACTGTCCAAGTGATTGTCCAGGCTCGACTTGGAGAAAAGATTTGCACCCGCTCATCATCTTCCCCGACGGGTTCAGATTGGTTCAATTTAGCAATCAAAGACATCCCAGAAGTCACCCATGAAGCAAAGAAGGCCCTGTCAGGGCAGCTGCCTGCTGTGGGGCGATCTATGTGTGTGGAAATCTCACTCAAGACTTCTGAGGGAGATTCTATGGAGTTGGAAATTTGGTGTCTTGAAATGAATGAAAAGTGTGACAAAGAAATCAAAGTTTCCTACACTGTATACAACCGATTGTCACTGCTGCTGAAGTCTCTTCTCGCTATTACAAGGGTGACACCAGCCTATCGACTCTCCAGGAAGCAA
Ensembl | 小鼠類登錄號
NCBI登錄號
運輸包裝
ambient
儲存溫度
−20°C
基因資訊
mouse ... ATG13(51897) , D2Ertd391e(51897)
一般說明
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
法律資訊
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
10 - Combustible liquids
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
Toshinori Sueda et al.
Scientific reports, 6, 18949-18949 (2016-01-12)
Although BRAF(V600E) mutation is associated with adverse clinical outcomes in patients with colorectal cancer (CRC), response and resistance mechanisms for therapeutic BRAF(V600E) inhibitors remains poorly understood. In the present study, we demonstrate that selective BRAF(V600E) inhibition activates AMP-activated protein kinase
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務